Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05281757 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

Study acronym: COSINE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Apr 2026 to Dec 2026v7
  2. Primary completion date: Mar 2026 to Apr 2026v6
  3. Re-verified, no change to tracked fieldsv5
  4. Primary completion date: Mar 2024 to Mar 2026 Study sites: 1 to 2 · Completion date: Oct 2026 to Oct 2028v4 Show 2 more changesShow less
    • Study sites: 1 to 2
    • Completion date: Oct 2026 to Oct 2028
  5. Re-verified, no change to tracked fieldsv3
  6. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 2022 to Feb 18, 2022 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Mar 2022 to Feb 18, 2022
    • Site details revised
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)
Trial Details
NCT Number NCT05281757
Lead Sponsor Aesculap AG
Collaborators: Raylytic GmbH
Conditions Hyperkyphosis, Hyperlordosis, Congenital Scoliosis, Neuromuscular Scoliosis, Idiopathic Scoliosis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov